Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Keppra 500mg tablets
0408010A0BBABAB
|
Keppra | Levetiracetam | Central Nervous System | 23,732 |
|
Keppra 250mg tablets
0408010A0BBAAAA
|
Keppra | Levetiracetam | Central Nervous System | 14,591 |
|
Keppra 1g tablets
0408010A0BBACAC
|
Keppra | Levetiracetam | Central Nervous System | 14,259 |
|
Keppra 100mg/ml oral solution
0408010A0BBADAH
|
Keppra | Levetiracetam | Central Nervous System | 8,774 |
|
Keppra 750mg tablets
0408010A0BBAEAI
|
Keppra | Levetiracetam | Central Nervous System | 6,098 |
|
Keppra 500mg/5ml concentrate for solution for infusion vials
0408010A0BBAFAJ
|
Keppra | Levetiracetam | Central Nervous System | 52 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.